ADC Review | Editorial Team | ADC Review | Page 2

Home Authors Posts by ADC Review | Editorial Team

632 POSTS 2 COMMENTS

The editorial team of ADC Review | Journal of Antibody-drug Conjugates (ISSN 2327-0152) consists of an Editor-in-Chief, Deputy Editors, and Consulting Editors. Members of the editorial team are chosen based on their demonstrated expertise in one or more areas of oncology or hematology and their active engagement in research, the development, manufacturing and clinical application of antibody-drug conjugates (ADCs).

Eisai & Co and Bliss Biopharmaceutical (Hangzhou) Sign Agreement to Jointly...

ADC Review | Editorial Team

What to Expect at ASCO 2023: SystImmune to Present Updates on...

ADC Review | Editorial Team

Mirvetuximab Soravtansine Demonstrates Overall Survival Benefit in FRα-Positive Platinum-Resistant Ovarian Cancer

ADC Review | Editorial Team

LaNova Medicines and LegoChem to Collaborate in ADC Development

ADC Review | Editorial Team

Peptide–drug Conjugate Sudocetaxel Zendusortide Shows Potential as a Single Agent and...

ADC Review | Editorial Team

ZB131 ADC Induce Potent Anti-tumor Activity CSP-expressing Tumors

ADC Review | Editorial Team

Polatuzumab vedotin-piiq (Polivy™) Packaging

FDA Approves Polatuzumab Vedotin Combination With R-CHP for People With Certain...

ADC Review | Editorial Team

Results of Preclinical Data for GQ1010 Confirm Potential for Best-In-Class TROP2-Targeted...

ADC Review | Editorial Team

AACR 2023: Preclinical Data Highlights Stable and Efficacious Low Drug-Load ADCs

ADC Review | Editorial Team

A Preclinical Profile of the Potential of BYON3521

ADC Review | Editorial Team

123...64 Page 2 of 64